Medicare Enrolled
Dr. Brett Wertman, M.D.
Cardiovascular Disease · Mission Viejo, CA
Practice pattern: Cardiac & Remote
— Practice combining cardiac and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wertman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wertman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wertman
Dr. Brett Wertman is a cardiovascular disease specialist in Mission Viejo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wertman performed 3,745 Medicare services across 2,200 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wertman received a total of $5,511 from 27 pharmaceutical and/or device companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wertman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in CA
$5,511 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,745
Medicare services
Top 29% in CA for cardiovascular disease
2,200
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~197 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,163 | $100 | $233 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
420 | $43 | $77 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
305 | $64 | $230 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
262 | $170 | $569 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
249 | $43 | $146 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
207 | $6 | $22 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
201 | $39 | $114 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
153 | $398 | $1,186 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
150 | $54 | $222 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
144 | $126 | $356 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
132 | $12 | $47 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
98 | $195 | $899 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
53 | $25 | $66 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
44 | $167 | $464 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
31 | $164 | $455 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
23 | $17 | $71 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
23 | $15 | $61 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
22 | $21 | $56 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
22 | $789 | $1,700 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $140 | $422 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
21 | $124 | $553 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.4% high complexity
32.1% medium
59.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,511
Total received (2018-2024)
Avg $787/year across 7 years
Top 38% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,313 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$935
2023
$795
2022
$955
2021
$723
2020
$833
2019
$1,021
2018
$250
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$155
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
PFIZER INC.
$85
AstraZeneca Pharmaceuticals LP
$65
BIOTRONIK INC.
$62
SANOFI-AVENTIS U.S. LLC
$61
Amgen Inc.
$52
E.R. Squibb & Sons, L.L.C.
$47
SCPHARMACEUTICALS INC.
$44
ATRICURE, INC.
$40
ABIOMED
$37
Janssen Pharmaceuticals, Inc
$34
Boston Scientific Corporation
$29
Merck Sharp & Dohme LLC
$23
Lexicon Pharmaceuticals, Inc.
$22
Abbott Laboratories
$20
Kiniksa Pharmaceuticals International, plc
$18
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$3,232
Boehringer Ingelheim Pharmaceuticals, Inc.
$222
Novartis Pharmaceuticals Corporation
$221
Astellas Pharma US Inc
$198
AtriCure, Inc.
$159
Amgen Inc.
$148
Medtronic Vascular, Inc.
$131
AstraZeneca Pharmaceuticals LP
$130
E.R. Squibb & Sons, L.L.C.
$118
Boston Scientific Corporation
$117
PFIZER INC.
$113
Bayer HealthCare Pharmaceuticals Inc.
$112
SANOFI-AVENTIS U.S. LLC
$95
Merck Sharp & Dohme LLC
$67
Medtronic, Inc.
$46
Edwards Lifesciences Corporation
$44
SCPHARMACEUTICALS INC.
$44
ATRICURE, INC.
$40
BOSTON SCIENTIFIC CORPORATION
$39
Abbott Laboratories
$37
ABIOMED
$37
Braemar Manufacturing, LLC
$34
Janssen Pharmaceuticals, Inc
$34
Kiniksa Pharmaceuticals, Ltd.
$28
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$24
Lexicon Pharmaceuticals, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$18
Top 3 companies account for 66.7% of all-time payments
Associated products mentioned in payments ›
ATRICLIP LAA EXCLUSION SYSTEM · Acticor · Acticor 7 VR-T DX · Arcalyst · BIOMONITOR · BioMonitor · CAMZYOS · Cardiac Monitoring Suite · ClosureFast · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora · Edora 8 DR-T · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · GENERAL THERAPIES · GENERAL BRADY · GENERAL - THERAPIES · Impella · JARDIANCE · Kerendia · LATITUDE Communicator Power Supply · LEQVIO · LifeVest · MITRACLIP · MULTAQ · Micra · Orsiro Mission · Repatha · Rivacor · Solia · TactiCath Quartz CFA Catheter · VENASEAL · VERQUVO · VYNDAQEL · VenaSeal · WAINUA · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
197
Per 100K population
6.2
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wertman is a cardiac & remote specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wertman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wertman performed 1,163 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wertman receive payments from pharmaceutical companies?
Yes. Dr. Wertman received a total of $5,511 from 27 companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wertman's costs compare to other cardiologists in Mission Viejo?
Dr. Wertman's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wertman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Mission Viejo
Browse cardiologists in Mission Viejo ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology